Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis

References

• Ogle OE, Mahjoubi G. Local anesthesia: agents, techniques, and complications. Dent Clin North Am. 2012;56(1):133–48 ix.
   PubMedGoogle Scholar
• Edmondson MA. Local, regional, and spinal anesthesia in ruminants. Vet Clin North Am Food Anim Pract. 2016;32(3):535–552.
   PubMed Web of Science ®Google Scholar
• Lirk P, Hollmann MW, Strichartz G. The science of local anesthesia: basic research, clinical application, and future directions. Anesth Analg. 2018;126(4):1381–1392.
   PubMed Web of Science ®Google Scholar
• Kary AL, Gomez J, Raffaelli SD, et al. Preclinical local anesthesia education in dental schools: a systematic review. J Dent Educ. 2018;82(10):1059–1064.
   PubMed Web of Science ®Google Scholar
• Locke MC, Davis JC, Brothers RJ, et al. Assessing the outcomes, risks, and costs of local versus general anesthesia: a review with implications for cutaneous surgery. J Am Acad Dermatol. 2018;78(5):983–8.e4.
   PubMed Web of Science ®Google Scholar
• An M, Su X, Wei M, et al. Local anesthesia combined with intra-articular ropivacaine can provide satisfactory pain control in ankle arthroscopic surgery: a retrospective cohort study. J Orthop Surg (Hong Kong). 2020;28(2):2309499020938122.
   Google Scholar
• Xing W, Chen DT, Pan JH, et al. Lidocaine induces apoptosis and suppresses tumor growth in human hepatocellular carcinoma cells in vitro and in a xenograft model in vivo. Anesthesiology. 2017;126(5):868–881.
   PubMed Web of Science ®Google Scholar
• Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology. 2012;116(4):841–856.
   PubMed Web of Science ®Google Scholar
• Hansen TG. Ropivacaine: a pharmacological review. Expert Rev Neurother. 2004;4(5):781–791.
   PubMedGoogle Scholar
• Casati A, Putzu M. Bupivacaine, levobupivacaine and ropivacaine: are they clinically different? Best Pract Res Clin Anaesthesiol. 2005;19(2):247–268.
   PubMedGoogle Scholar
• Cheng Q, Bi X, Zhang W, et al. Dexmedetomidine versus sufentanil with high- or low-concentration ropivacaine for labor epidural analgesia: a randomized trial. J Obstet Gynaecol Res. 2019;45(11):2193–2201.
   PubMed Web of Science ®Google Scholar
• Chen G, Gong M, Liu Y. Comparison of ropivacaine plus sufentanil and ropivacaine plus dexmedetomidine for labor epidural analgesia: a randomized controlled trial protocol. Medicine (Baltimore). 2020;99(36):e22113.
   PubMed Web of Science ®Google Scholar
• Beguinot M, Monrigal E, Kwiatkowski F, et al. Continuous wound infiltration with ropivacaine after mastectomy: a randomized controlled trial. J Surg Res. 2020;254:318–326.
   PubMed Web of Science ®Google Scholar
• Bundscherer A, Malsy M, Gebhardt K, et al. Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res. 2015;95-96:126–131.
   PubMed Web of Science ®Google Scholar
• Yang W, Cai J, Zhang H, et al. Effects of lidocaine and ropivacaine on gastric cancer cells through down-regulation of ERK1/2 phosphorylation in vitro. Anticancer Res. 2018;38(12):6729–6735.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Peng X, Zheng Q. Ropivacaine inhibits the migration of esophageal cancer cells via sodium-channel-independent but prenylation-dependent inhibition of Rac1/JNK/paxillin/FAK. Biochem Biophys Res Commun. 2018;501(4):1074–1079.
   PubMed Web of Science ®Google Scholar
• George AM, Liu M. Ropivacaine. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.
   Google Scholar
• Ropivacaine. Drugs and Lactation Database (LactMed). Bethesda (MD): National Library of Medicine (US; 2006.
   Google Scholar
• Zhang J, Zhu S, Tan Q, et al. Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief. Theranostics. 2020;10(11):4885–4899.
   PubMed Web of Science ®Google Scholar
• Yang J, Li G, Bao K, et al. Ropivacaine inhibits tumor angiogenesis via sodium-channel-independent mitochondrial dysfunction and oxidative stress. J Bioenerg Biomembr. 2019;51(3):231–238.
   PubMed Web of Science ®Google Scholar
• Hakuno F, Takahashi SI. IGF1 receptor signaling pathways. J Mol Endocrinol. 2018;61(1):T69–t86.
   PubMed Web of Science ®Google Scholar
• Qu X, Wu Z, Dong W, et al. Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy. Oncotarget. 2017;8(17):29501–29518.
   PubMedGoogle Scholar
• Fruman DA, Chiu H, Hopkins BD, et al. The PI3K pathway in human disease. Cell. 2017;170(4):605–635.
   PubMed Web of Science ®Google Scholar
• Porta C, Paglino C, Mosca A. Targeting PI3K/Akt/mTOR signaling in cancer. Front Oncol. 2014;4:64.
   PubMedGoogle Scholar
• Lien EC, Dibble CC, Toker A. PI3K signaling in cancer: beyond AKT. Curr Opin Cell Biol. 2017;45:62–71.
   PubMed Web of Science ®Google Scholar
• Aoki M, Fujishita T. Oncogenic roles of the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153–189.
   PubMed Web of Science ®Google Scholar
• Bentov I, Damodarasamy M, Spiekerman C, et al. Lidocaine impairs proliferative and biosynthetic functions of aged human dermal fibroblasts. Anesth Analg. 2016;123(3):616–623.
   PubMed Web of Science ®Google Scholar
• Zhao T, Wang Q. Capillarisin protects SH-SY5Y cells against bupivacaine-induced apoptosis via ROS-mediated PI3K/PKB pathway. Life Sci. 2020;259:118279.
   PubMed Web of Science ®Google Scholar
• Verlinde M, Hollmann MW, Stevens MF, et al. Local anesthetic-induced neurotoxicity. Int J Mol Sci. 2016;17(3):339.
   PubMed Web of Science ®Google Scholar
• Kwakye AK, Kampo S, Lv J, et al. Levobupivacaine inhibits proliferation and promotes apoptosis of breast cancer cells by suppressing the PI3K/Akt/mTOR signalling pathway. BMC Res Notes. 2020;13(1):386.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee S, Chin KJ, et al. Comparison of the onset time between 0.375% ropivacaine and 0.25% levobupivacaine for ultrasound-guided infraclavicular brachial plexus block: a randomized-controlled trial. Sci Rep. 2021;11(1):4703.
   PubMed Web of Science ®Google Scholar
• Kallio H, Snäll EV, Kero MP, et al. A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10 mg. Anesth Analg. 2004;99(3):713–717. table of contents.
   PubMed Web of Science ®Google Scholar
• Wang W, Zhu M, Xu Z, et al. Ropivacaine promotes apoptosis of hepatocellular carcinoma cells through damaging mitochondria and activating caspase-3 activity. Biol Res. 2019;52(1):36.
   PubMed Web of Science ®Google Scholar
• Wang H, Wu D, Cai L, et al. Aberrant methylation of WD-repeat protein 41 contributes to tumour progression in triple-negative breast cancer. J Cell Mol Med. 2020;24(12):6869–6882.
   PubMed Web of Science ®Google Scholar
• Sun C, Li G, Liu M. A novel circular RNA, circ_0005394, predicts unfavorable prognosis and contributes to hepatocellular carcinoma progression by regulating miR-507/E2F3 and miR-515-5p/CXCL6 signaling pathways. Onco Targets Ther. 2020;13:6171–6180.
   PubMed Web of Science ®Google Scholar
• Qin A, Liu Q, Wang J. Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression. Drug Dev Res. 2020;81(6):700–707.
   PubMed Web of Science ®Google Scholar
• Zhang N, Xing X, Gu F, et al. Ropivacaine inhibits the growth, migration and invasion of gastric cancer through attenuation of WEE1 and PI3K/AKT signaling via miR-520a-3p. Onco Targets Ther. 2020;13:5309–5321.
   PubMed Web of Science ®Google Scholar
• Loh CY, Chai JY, Tang TF, et al. The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges. Cells. 2019;8(10):10.
   Web of Science ®Google Scholar
• Liu H, Dilger JP, Lin J. Effects of local anesthetics on cancer cells. Pharmacol Ther. 2020;212:107558.
   PubMed Web of Science ®Google Scholar
• Hu Y, Qin X, Cao H, et al. Reversal effects of local anesthetics on P-glycoprotein-mediated cancer multidrug resistance. Anticancer Drugs. 2017;28(3):243–249.
   PubMed Web of Science ®Google Scholar
• Shen S, Vagner S, Robert C. Persistent cancer cells: the deadly survivors. Cell. 2020;183(4):860–874.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105–111.
   PubMed Web of Science ®Google Scholar
• Tam KW, Chen SY, Huang TW, et al. Effect of wound infiltration with ropivacaine or bupivacaine analgesia in breast cancer surgery: a meta-analysis of randomized controlled trials. Int J Surg. 2015;22:79–85.
   PubMed Web of Science ®Google Scholar
• Yin D, Liu L, Shi Z, et al. Ropivacaine inhibits cell proliferation, migration and invasion, whereas induces oxidative stress and cell apoptosis by circSCAF11/miR-145-5p axis in glioma. Cancer Manag Res. 2020;12:11145–11155.
   PubMed Web of Science ®Google Scholar
• Toki K, Yokose M, Miyashita T, et al. [Involuntary movement of bilateral lower limbs caused by epidural anesthesia: a case Report]. Masui. 2016;65(6):628–631.
   PubMedGoogle Scholar
• Le Gac G, Angenard G, Clément B, et al. Local anesthetics inhibit the growth of human hepatocellular carcinoma cells. Anesth Analg. 2017;125(5):1600–1609.
   PubMed Web of Science ®Google Scholar
• Huang J, Liu X, Ding S, et al. Hydrochloride with Fentanyl versus large-dose of ropivacaine hydrochloride for cesarean section. J Coll Physicians Surg Pak. 2019;29(4):301–304.
   PubMed Web of Science ®Google Scholar
• Williams GH, Stoeber K. The cell cycle and cancer. J Pathol. 2012;226(2):352–364.
   PubMed Web of Science ®Google Scholar
• Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature. 2001;411(6835):342–348.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu W, Guo X, et al. Ropivacaine inhibits cervical cancer cell growth via suppression of the miR‑96/MEG2/pSTAT3 axis. Oncol Rep. 2020;43(5):1659–1668.
   PubMed Web of Science ®Google Scholar
• Zhao L, Han S, Hou J, et al. The local anesthetic ropivacaine suppresses progression of breast cancer by regulating miR-27b-3p/YAP axis. Aging (Albany NY). 2021;13(12):16341-16352.
   Google Scholar
• Chen W, Xu Y, Zhang Y, et al. Positive impact of intraoperative epidural ropivacaine infusion on oncologic outcomes in pancreatic cancer patients undergoing pancreatectomy: a retrospective cohort study. J Cancer. 2021;12(15):4513–4521.
   PubMed Web of Science ®Google Scholar
• Wang HW, Wang LY, Jiang L, et al. Amide-linked local anesthetics induce apoptosis in human non-small cell lung cancer. J Thorac Dis. 2016;8(10):2748–2757.
   PubMed Web of Science ®Google Scholar
• Wang XX, Zhang B, Xia R, et al. Inflammation, apoptosis and autophagy as critical players in vascular dementia. Eur Rev Med Pharmacol Sci. 2020;24(18):9601–9614.
   PubMed Web of Science ®Google Scholar
• Morris G, Walker AJ, Berk M, et al. Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol. 2018;55(7):5767–5786.
   PubMed Web of Science ®Google Scholar
• Kontargiris E, Kolettas E, Vadalouca A, et al. Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine. Cell Res. 2004;14(5):415–422.
   PubMed Web of Science ®Google Scholar
• Zheng T, Zheng CY, Zheng XC, et al. Effect of parthanatos on ropivacaine-induced damage in SH-SY5Y cells. Clin Exp Pharmacol Physiol. 2017;44(5):586–594.
   PubMed Web of Science ®Google Scholar
• Piegeler T, Votta-Velis EG, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117(3):548–559.
   PubMed Web of Science ®Google Scholar
• Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol. 2004;48(5–6):463–476.
   PubMed Web of Science ®Google Scholar
• Vernieri C, Galli F, Ferrari L, et al. Impact of metformin use and diabetic status during adjuvant fluoropyrimidine-oxaliplatin chemotherapy on the outcome of patients with resected colon cancer: a TOSCA study subanalysis. Oncologist. 2019;24(3):385–393.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Q, Lu J, et al. Lidocaine promotes autophagy of SH-SY5Y cells through inhibiting PI3K/AKT/mTOR pathway by upregulating miR-145. Toxicol Res (Camb). 2020;9(4):467–473.
   PubMed Web of Science ®Google Scholar
• Zheng Q, Peng X, Yu H. Local anesthetic drug inhibits growth and survival in chronic myeloid leukemia through suppressing PI3K/Akt/mTOR. Am J Med Sci. 2018;355(3):266–273.
   PubMed Web of Science ®Google Scholar